About this trial
Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Several ocular conditions are accompanied by photophobia, ranging from mild to debilitating.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subjects must have worn FL-41 tinted spectacles for at least one month prior to participating in this study.
Subjects must have at least 20/30 distance visual acuity in each eye while wearing the contact lenses. Altius lenses are currently available in spherical powers from plano to -6.00.
Subjects must demonstrate the ability to insert and remove contact lenses. Assistance from friends and family is acceptable.
Subjects must not have an infectious or progressive ocular disease.
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
DeviceBiomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
Treatment groups
Trial outcomes
Primary outcomes
Comparing FL-41 Tinted Eyeglasses, Biomedics 55 Premier, and Altius Grey-Green Tinted Contacts
questionnaires - scale of 1 to 10 - no light sensitivity and 10 extreme light sensitivity
Secondary outcomes
Evaluating FL-41 Tinted Spectacles
questionnaire - scale 1-10 :1-no light sensitivity and 10 extreme light sensitivity
Evaluating Biomedics 55 Premier Contacts
questionnaire - scale 1-10 :1-no light sensitivity and 10 extreme light sensitivity
Evaluating Altius Grey-Green Tinted Contacts
questionnaire - scale 1-10 :1-no light sensitivity and 10 extreme light sensitivity
Evaluating Altius Amber Tinted Contacts
questionnaire - scale 1-10 :1-no light sensitivity and 10 extreme light sensitivity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Oklahoma
Lead sponsor
Dean A. McGee Eye Institute
Collaborator
This trial is not recruiting at the moment. You can still explore other options: